Log in
Enquire now

List of BioLamina AB patents

List of BioLamina AB patents
List of Skylotec patents
List of Altair Engineering Inc patents
List of Julius Blum patents
List of companies in Sidekick Partners's investment portfolio
List of AI access management companies
Patents where
Current Assignee
Name
is
‌
BioLamina AB
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 8415156 Recombinant laminin-521

Patent 8415156 was granted and assigned to BioLamina AB on April, 2013 by the United States Patent and Trademark Office.

‌
BioLamina AB
United States Patent and Trademark Office
United States Patent and Trademark Office
8415156
April 9, 2013
‌
US Patent 10138292 Cell culture medium

Patent 10138292 was granted and assigned to BioLamina AB on November, 2018 by the United States Patent and Trademark Office.

‌
BioLamina AB
United States Patent and Trademark Office
United States Patent and Trademark Office
10138292
November 27, 2018
‌
US Patent 9719066 Stem cell bank

Patent 9719066 was granted and assigned to BioLamina AB on August, 2017 by the United States Patent and Trademark Office.

‌
BioLamina AB
‌
BioLamina AB
United States Patent and Trademark Office
United States Patent and Trademark Office
9719066
August 1, 2017
‌
US Patent 9499794 Maintenance of differentiated cells with laminins

Patent 9499794 was granted and assigned to BioLamina AB on November, 2016 by the United States Patent and Trademark Office.

‌
BioLamina AB
United States Patent and Trademark Office
United States Patent and Trademark Office
9499794
November 22, 2016
‌
US Patent 10889801 Methods of producing RPE cells

Patent 10889801 was granted and assigned to BioLamina AB on January, 2021 by the United States Patent and Trademark Office.

‌
BioLamina AB
‌
BioLamina AB
United States Patent and Trademark Office
United States Patent and Trademark Office
10889801
January 12, 2021
‌
US Patent 10344259 Methods and compositions for producing stem cell derived dopaminergic cells for use in treatment of neurodegenerative diseases

Patent 10344259 was granted and assigned to BioLamina AB on July, 2019 by the United States Patent and Trademark Office.

‌
BioLamina AB
‌
BioLamina AB
United States Patent and Trademark Office
United States Patent and Trademark Office
10344259
July 9, 2019
‌
US Patent 9534038 Isolated laminin-421

Patent 9534038 was granted and assigned to BioLamina AB on January, 2017 by the United States Patent and Trademark Office.

‌
BioLamina AB
United States Patent and Trademark Office
United States Patent and Trademark Office
9534038
January 3, 2017
‌
US Patent 9828630 Methods of enhancing genetic diagnosis

Patent 9828630 was granted and assigned to BioLamina AB on November, 2017 by the United States Patent and Trademark Office.

‌
BioLamina AB
‌
BioLamina AB
United States Patent and Trademark Office
United States Patent and Trademark Office
9828630
November 28, 2017
‌
US Patent 11236302 Methods and compositions for producing stem cell derived dopaminergic cells for use in treatment of neurodegenerative diseases

Patent 11236302 was granted and assigned to BioLamina AB on February, 2022 by the United States Patent and Trademark Office.

‌
BioLamina AB
‌
BioLamina AB
United States Patent and Trademark Office
United States Patent and Trademark Office
11236302
February 1, 2022
‌
US Patent 10829733 Composition and method for enabling proliferation of pluripotent human stem cells

‌
BioLamina AB
United States Patent and Trademark Office
United States Patent and Trademark Office
10829733
November 10, 2020
‌
US Patent 11155781 Maintenance of differentiated cells with laminins

Patent 11155781 was granted and assigned to BioLamina AB on October, 2021 by the United States Patent and Trademark Office.

‌
BioLamina AB
‌
BioLamina AB
United States Patent and Trademark Office
United States Patent and Trademark Office
11155781
October 26, 2021
‌
US Patent 10240124 Cell culture substrate comprising a laminin and a cadherin

Patent 10240124 was granted and assigned to BioLamina AB on March, 2019 by the United States Patent and Trademark Office.

‌
BioLamina AB
‌
BioLamina AB
United States Patent and Trademark Office
United States Patent and Trademark Office
10240124
March 26, 2019
‌
US Patent 11767509 Methods of producing RPE cells

Patent 11767509 was granted and assigned to BioLamina AB on September, 2023 by the United States Patent and Trademark Office.

‌
BioLamina AB
‌
BioLamina AB
United States Patent and Trademark Office
United States Patent and Trademark Office
11767509
September 26, 2023
13 results
0 selected
13 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us